Introduction
Mitochondrial dynamics has recently emerged as an important regulatory process in cellular bioenergetics, apoptosis and disease. 1 Mitochondria exist as dynamic networks alternating between fusion and fission states that allow for the exchange and movement of cellular components such as mtDNA, proteins, ATP and lipids. This process is necessary for the proper maintenance of mitochondrial homeostasis and its misregulation is directly linked to a variety of human disease states.
One of the best studied regulatory mechanisms that is intimately linked to mitochondrial morphology is the cellular apoptotic machinery. 2 Mitochondria serve as cellular sentinels that detect, integrate and propagate death signals. The key factors participating in this process are members of the Bcl-2 family of proteins which regulate membrane permeabilization and the release of pro-apoptotic factors such as cytochrome c and Smac/ DIABLO, thus triggering cell death. 3 Recently, studies have suggested an uncoupling between Bcl-2 family-mediated cell survival and mitochondrial dynamics. 4 For example, different forms of Mcl-1 were shown to reside in distinct mitochondrial locations where they perform separate functions. 5 Bcl xL is a key pro-survival member of the Bcl-2 family whose sole overexpression is sufficient to inhibit cell death. 6 The role of Bcl xL in mitochondrial dynamics is not clear; overexpression of Bcl xL increased mitochondrial fission in ~50% of cells while the remaining cells exhibited increased mitochondrial fusion. 7, 8 Similarly, re-expression of Bcl xL in Bcl xL -null mice promoted both fusion and fission rates and mitochondrial mass in healthy Bcl xL is a key prosurvival factor that in addition to controlling mitochondrial membrane permeability regulates mitochondrial network dynamics. The expression of Bcl xL is regulated at the level of transcription, splicing and selective translation. In this study, we show that the RNA-binding protein huR, which is known to orchestrate an anti-apoptotic cellular program, functions as a translational repressor of Bcl xL . We show that huR binds directly to the 5'UTR of Bcl xL , and represses Bcl xL translation through the inhibition of its internal ribosome entry site (IRes). Reduction of huR levels leads to the derepression of Bcl xL translation and subsequent rearrangement of the mitochondrial network. Our results place Bcl xL into the huR-regulated operon and provide further insight into the regulation of cellular stress response by huR. Danielle Durie,  1 Maria hatzoglou,  2 pranesh chakraborty  3,4 and Martin holcik 1,3, neurons. 9 The expression of Bcl xL is known to be regulated at the level of transcription and alternative splicing. 10, 11 In particular, Bcl-x pre-mRNA can be spliced into a long, anti-apoptotic isoform (xL) or a short, pro-apoptotic isoform (xS). Various stimuli, along with different splicing factors regulate the switch between these isoforms. For instance, mitogenic pathways promote the expression of the xL isoform whereas the sphingolipid ceramide stimulates expression of the xS isoform. The relative levels of these factors determine whether cells will be resistant to death triggers or engage in apoptosis. 11 Additional point of Bcl xL regulation was identified recently. Yoon and colleagues have shown that translation of Bcl xL mRNA is specifically impaired in cells harbouring mutation of dyskerin, the gene mutated in patients suffering from Dyskeratosis congenita. 12 They further demonstrated that the 5' UTR of Bcl xL harbours an IRES element which drives Bcl xL translation under stress. Additional recent reports confirmed the 5' UTR of Bcl xL as a key regulatory cis-element controlling expression of Bcl xL . Cytoplasmic accumulation of hnRNP A1 in cells undergoing osmotic shock was shown to inhibit Bcl xL mRNA translation by binding to the 5' UTR and tipping the survival balance in favor of apoptosis. 13 Similarly, binding of PDCD4 to the 5' UTR of Bcl xL specifically repressed Bcl xL translation, and this repression was relieved in cells treated in FGF-2, resulting in the degradation of PDCD4 and de-repression of Bcl xL translation, thus contributing to enhanced chemoresistance. 14 In the present study we demonstrate a link between the translational control of Bcl xL expression and mitochondrial morphology. We show that an RNA binding protein HuR specifically and directly binds to the 5' UTR of Bcl xL and functions as a repressor reducing the levels of HuR had no effect on the expression of closely related members of the Bcl-2 family of proteins, Bcl-2 and Mcl-1 (Fig. 1B) . Importantly, the increase in Bcl xL protein levels caused by reduction in HuR could be significantly blunted by restoring the levels of HuR (Fig. 1C and D) . These observations suggest that HuR is a negative regulator of Bcl xL expression.
HuR controls mitochondrial morphology through the regulation of Bcl xL translation
To further demonstrate that HuR controls the translation and not the steady-state levels of endogenous Bcl xL mRNA we examined the mRNA levels of Bcl xL by quantitative RT-PCR in cells in which the expression of HuR was either reduced by siRNA, or increased by ectopic expression. Bcl xL is one of the two alternatively spliced variants of the Bcl x gene; 16 we therefore determined the steady-state levels of both Bcl xL and Bcl xS splice isoforms using a common primer set (Bcl x ; Fig. 2A ) and specifically just that of Bcl xL (Fig. 2B) . We found that modulating the levels of HuR had no effect on the abundance of Bcl xL mRNA. Furthermore, to eliminate the possibility that the increase in Bcl xL is due to the change in the splicing ratio between Bcl xL and Bcl xS we examined the abundance of each isoform by isoform specific RT-PCR. Again, we didn't observe any differences in the ratio of the two isoforms in cells with reduced expression of HuR (Fig.  2C) . To demonstrate that HuR indeed controls the translation of of Bcl xL translation in cells. Reduction in HuR levels by siRNA results in marked increase in Bcl xL expression and subsequent fragmentation of the mitochondrial network. Our results suggest that HuR contributes to the maintenance of the mitochondrial network by controlling Bcl xL expression.
Results
HuR is a translational repressor of Bcl xL . We have shown recently that HuR regulates translation of XIAP through the interaction with the XIAP 5' UTR. 15 Since XIAP and Bcl xL translation were shown to be coordinately regulated [12] [13] [14] we hypothesized that HuR might also control translation of Bcl xL . We therefore examined whether modulating levels of HuR, either by knockdown with small interfering RNA (siRNA) or by overexpression, have any effect on the translation of endogenous Bcl xL mRNA. U2OS cells were transiently transfected with either HuR-targeting or non-silencing control siRNA and the levels of Bcl xL protein were determined 72 h later by western blot analysis. We found that reducing the levels of HuR by siRNA resulted in ~3.5 fold increase in Bcl xL protein levels compared with a non-silencing control (Fig. 1A) . This increase in expression was specific to Bcl xL , since in cells with reduced levels of HuR (Fig. 2E) . We could not test de novo synthesis of Bcl xL , as the anti-Bcl xL antibody did not precipitate sufficient amount of labeled Bcl xL for analysis. However, reverse transcriptase-PCR amplification of Bcl xL mRNA from individual polysome fractions showed increased polysome association in cells with reduced HuR levels ( Fig. 2F ), in keeping with the notion that HuR functions as a translation repressor of Bcl xL .
HuR represses Bcl xL translation through interaction with its 5' UTR. We wished to elucidate the molecular basis for the translational repression of Bcl xL by HuR. In previously published reports HuR was frequently found to interact with the 5' UTR regions of mRNAs whose translation was regulated by HuR. 15, [17] [18] [19] We therefore questioned whether HuR interacts with the 5' endogenous Bcl xL mRNA, we used polysome profiling to examine the association of Bcl xL mRNA with translating ribosomes in cells with reduced levels of HuR. Because we were unable to obtain sufficient amount of ribosomes-associated RNA from U2OS cells, we used HEK293 cells which recapitulate the HuRmediated changes in Bcl xL expression seen in U2OS cells (data not shown). We observed that reducing HuR levels by siRNA had no measurable effect on the overall polysome profile (Fig.  2D) , indicating that reduced levels of HuR do not affect global rate of protein synthesis. This was further corroborated by measuring 35 S-Met incorporation which indicated no measurable difference in global de novo protein synthesis, nor a difference in de novo synthesis of GAPDH, a representative house-keeping gene, basal IRES activity 12 (and data not shown) and we were therefore unable to test this construct in cells. Similarly, we were unable to perform the converse experiment, since downregulation of HuR by siRNA caused rapid degradation of the reporter RNA irrespective of which reporter plasmid was used in the assay.
HuR regulates mitochondrial morphology through Bcl xL . Members of the Bcl-2 family of proteins, including Bcl xL regulate the morphology of the mitochondrial network. 4, 20 We therefore wished to investigate if reducing the levels of HuR, and the consequent increase in Bcl xL expression, would impact mitochondrial morphology. U2OS cells were transiently transfected with siRNA targeting HuR or a non-silencing control, and the mitochondrial network was visualized 72 h later by staining the fixed cells for the outer mitochondrial marker Tom20. We observed that there was a 2.2-fold increase in fragmented mitochondria in HuR siRNA treated cells when compared with cells treated with non-silencing siRNA ( Fig. 4A and B) . Importantly, siRNAmediated knockdown of Bcl xL significantly reduced the portion of fragmented mitochondria ( Fig. 4A and B) . These results indicate that the induction of Bcl xL expression through HuR downregulation contributes to the rearrangement of the mitochondrial network.
Discussion
Bcl xL is a key component of the cellular anti-apoptotic machinery. In addition to regulating the release of pro-apoptotic mitochondrial factors such as cytochrome c and Smac/DIABLO, recent data suggests that Bcl xL also actively participates in the control of mitochondrial dynamics that is independent of the regulation of apoptosis. 4 We and others have shown that in addition to the regulation of Bcl xL splicing and transcription, control of Bcl xL translation is the key regulatory step, in particular in response to cellular stress. [12] [13] [14] The 5' UTR of Bcl xL was shown to harbour an IRES element that allows the Bcl xL mRNA to be translated in times of cellular stress when global translation is attenuated. Translation of the majority of cellular mRNAs under normal growth conditions occurs by a cap-dependent mechanism that requires interaction of specific initiation factors with the 5' cap of the mRNA, followed by recruitment of ribosomal subunits, recognition of the AUG start codon and commencement of polypeptide chain elongation. 21 In contrast, IRESmediated translation initiation was identified as key mechanism which supports cap-independent translation under conditions of cellular stress such as nutrient deprivation, hypoxia or gamma irradiation. 22 Although the precise mechanism of cellular IRES translation remains unclear, it has been postulated that cellular IRES require some of the canonical initiation factors as well as auxiliary proteins (termed IRES trans-acting factors, ITAFs) for their proper function. 23, 24 Two such factors were identified previously for the Bcl xL IRES. hnRNP A1, which accumulates in the cytoplasm in response to various forms of cellular stress, was shown to bind to the 5' UTR of Bcl xL and to attenuate its translation during osmotic stress. 13 Although the precise mechanism of this inhibition was not elucidated, it was suggested that hnRNP A1 specifically sequesters Bcl xL in stress granules in response to UTR of Bcl xL as well. To determine whether HuR binds directly to the Bcl xL 5' UTR we performed a UV-crosslinking experiment using a radiolabelled Bcl xL 5' UTR RNA probe and purified recombinant GST-HuR. Increasing amounts of GST-HuR were incubated with [
32 P]-labeled full length Bcl xL 5' UTR RNA ( Fig. 3A ; probe A), followed by crosslinking and separation by SDS-PAGE. We found that Bcl xL 5' UTR RNA is crosslinked to GST-HuR in a dose-dependent manner (Fig. 3B) , indicating that HuR does indeed bind directly to Bcl xL 5' UTR.
We further assessed the interaction between HuR and the Bcl xL 5' UTR by measuring the apparent equilibrium dissociation constant (K d ) of the recombinant GST-HuR and Bcl xL 5' UTR RNA. To determine the K d of this interaction we performed a nitrocellulose filter binding assay, in which varying amounts of GST-HuR are incubated with a constant amount of RNA. We found the K d for the interaction between GST-HuR and Bcl xL 5' UTR RNA is 105 ± 61 nM (Fig. 3C) . In order to determine the region of HuR interaction with the Bcl xL 5' UTR we generated a series of deletions (Fig. 3A) which were subsequently subjected to the filter binding assay with GST-HuR as described above. We found that GST-HuR does not effectively bind probes B, C, and E ( Fig. 3C; we were unable to determine the actual K d value because we were unable to saturate binding). In contrast, probe D of the Bcl xL 5' UTR showed strong binding with the K d similar to that of the full length RNA (132 ± 40 nM). Importantly, deletion of segment D from the full length 5' UTR failed to bind GST-HuR ( Fig. 3C; probe F) . Therefore, HuR specifically associates with Bcl xL 5' UTR RNA.
We have shown that cellular levels of HuR control translation of Bcl xL and that HuR binds to the 5' UTR region of Bcl xL mRNA. The 5' UTR of Bcl xL harbours an IRES element that controls translation of the Bcl xL mRNA under various physiological and pathophysiological conditions. [12] [13] [14] We therefore examined whether modulating levels of HuR has any effect on the activity of Bcl xL IRES. To assess Bcl xL IRES activity, we used a previously characterized bicistronic reporter plasmid containing the Bcl xL IRES (pßgal/BclxL/CAT 13, 14 ) . In this construct, expression of the first cistron (β-galactosidase, βgal) is cap dependent, whereas expression of the second cistron (chloramphenicol acetyl transferase, CAT) is driven by Bcl xL 5' UTR. HEK293 cells were transiently co-transfected with pßgal/BclxL/CAT reporter plasmid and with either GFP-or a GFP-HuR expressing plasmid. We found that overexpression of GFP-HuR caused ~60% reduction in CAT expression compared with that of a GFP control (Fig.  3D) . In contrast, overexpression of GFP-HuR had no effect on the expression of βgal. This observation was somewhat surprising since we have reported previously that overexpression of HuR caused a decrease in overall translation; 15 however, the decrease in global translation was observed by polysome profile analysis whereas in the current study we only followed expression of a single, ectopically expressed transgene. Overexpression of GFPHuR had no effect on the expression of either reporter protein from the control plasmid pßgal/CAT, suggesting that HuR specifically regulates translation controlled by the Bcl xL 5' UTR. We wished to test the activity of Bcl xL 5' UTR deleted of the HuR binding site (probe F). However, this deletion causes the loss of is a tumor suppressor which was shown to act as an inhibitor of eIF4A, an RNA helicase component of the eIF4F complex hypertonic stress, thus inhibiting its translation. The second protein that similarly inhibits Bcl xL translation is PDCD4. 14 PDCD4 loss of HuR results in enhanced recruitment of Bcl xL mRNA into polyribosomes and increase in Bcl xL protein levels. Interestingly, the same three Bcl xL ITAFs were also shown to regulate expression of another anti-apoptotic protein, XIAP 14, 15, 29 suggesting an existence of a common regulatory network(s) that may control selective translation of mRNAs involved in the regulation of cell survival in response to stress. However, in contrast to hnRNP A1 and PDCD4, HuR functions as an enhancer of XIAP but a repressor of Bcl xL translation. Such dichotomy has been shown for HuR previously since it inhibits translation of some (e.g., p27; 30 ) while enhancing activity of other (e.g., HCV;
31
) IRES. Although the basis for this dichotomy is not known, it is possible that conformational changes elicited by the binding of HuR to some IRES will render these elements non-functional, while binding to other IRES will induce conformation that is amenable to ribosome recruitment. In addition, the cohort of other ITAFs and possibly canonical initiation factors, which seems to be more or less distinct for various IRES elements, will play a significant which is required for the recruitment of capped mRNA to the ribosome. 25 Although PDCD4 is generally viewed as a general translation repressor, recent evidence suggests that PDCD4 preferentially represses mRNA with highly structured 5' UTRs 26, 27 and those harbouring an IRES. 14 We have shown previously that PDCD4 specifically interacts with the 5' UTRs of at least two anti-apoptotic factors, XIAP and Bcl xL , and mediates repression of their translation by interfering with the assembly of the 48S initiation complex.
14 In response to FGF-2 treatment of cells, PDCD4 is phosphorylated by S6K2 and targeted for proteosomal degradation, thus de-repressing translation of Bcl xL and resulting in enhanced chemoresistance. 14, 28 In the present study we have identified a third repressor of Bcl xL translation. We show that HuR binds directly and specifically to the 5' UTR of Bcl xL . Importantly, we showed that HuR translationaly regulates Bcl xL through the IRES element located within the 5' UTR. Using the 5' UTR reporter construct we demonstrated that the IRES activity of Bcl xL decreases upon overexpression of HuR, while the transfection). Cells were harvested 24 h later for RNA extraction or Western Blot analysis. For rescue experiments, 1.5x10 5 cells were first reverse transfected with 10 nM HuR siRNA or non-silencing control for 48 h, then 2 μg of GFP or GFP-HuR plasmid DNA was forward transfected for an additional 24 h and cells were harvested for further analysis.
UV-crosslinking and nitrocellulose filter binding assays of RNA-protein complexes. Radioactive Bcl xL 5' UTR probes for UV-crosslinking and nitrocellulose filter binding assays were prepared by an in vitro transcription using Maxiscript ® kit (Ambion) and gel purified. RNA-protein UV-crosslinking experiments and the nitrocellulose binding assay were conducted as previously described. 14, 15 β-galactosidase and CAT analysis. Transiently transfected cells were washed in 1 ml of phosphate-buffered saline and harvested in 300 μl CAT ELISA kit lysis buffer according to the protocol provided by the manufacturer (Roche Molecular Biochemicals). β-galactosidase (β-gal) enzymatic activity was determined by spectrophotometric assay using o-nitrophenyl-β-D-galactopyranoside as previously described. 43 CAT levels were determined using the CAT ELISA kit according to the protocol provided by the manufacturer (Roche Molecular Biochemicals).
Western blot analysis. Cells were washed in 1 ml phosphatebuffered saline and lysed in 150 μl RIPA buffer (50 mM Tris base pH 7.4, 1 mM EDTA, 150 mM NaCl, 1% NP-40, 0.5% SDS, 0.25 g deoxycholate in 50 mL water; 1 mM PMSF and 10 μg/mL leupeptin were added fresh) for 30 min at 4°C, followed by centrifugation at 12,000 g for 10 min to pellet debris. Protein concentration was determined by the BCA Protein Assay Kit (Pierce Biotechnology) and equal amounts of protein extract were separated by 10% SDS-PAGE and transferred to nitrocellulose membrane by wet transfer. Samples were analyzed by western blotting using rabbit anti-Bcl xL (Cell Signaling Technologies), mouse monoclonal anti-HuR (Santa Cruz Biotechnology), mouse anti-GAPDH (Advanced Immunochemical Inc.), mouse anti-Tubulin (Abcam), rabbit anti-Mcl-1 (Santa Cruz Biotechnology), or rabbit anti-Bcl-2 (Cell Signaling Technologies) followed by secondary antibody (horseradish peroxidase-conjugated anti-mouse or anti-rabbit IgG; Cell Signaling Technologies). Antibody complexes were detected using the ECL or ECL Plus systems (GE Healthcare) and were quantified using Odyssey densitometry software (Li-Cor, Lincoln).
RNA extraction, RT-PCR and quantitative RT-PCR analysis. Total RNA was isolated from transfected cells using RNazol according to the manufacturer's instructions (Molecular Research Center). cDNA was generated using an oligo dT18 primer and the qScript TM cDNA Supermix according to the protocol provided by the manufacturer (Quanta Biosciences). The synthesized cDNA was used as the template for quantitative PCR using the QuantiTect SYBR Green PCR kit (Qiagen) along with gene specific primers for Bcl x , Bcl xL (QuantiTect Primer Assay, Qiagen), and GAPDH, 15 and analyzed on a Mastercycler realplex (Eppendorf) real-time thermocycler using the associated realplex software. Relative expression levels were determined using the standard curve method. Controls lacking RT demonstrated no significant genomic DNA amplification (> 10 cycle difference).
role in rendering HuR a repressor or activator of the given IRES. Of note, translation of Bcl xL mRNA was shown previously to be significantly enhanced by overexpression of the cap-binding protein eIF4E 32 and this increase led to the inhibition of cytochrome c release from the mitochondria. Interestingly, the cohorts of HuR and eIF4E targets are at least partially overlapping 33 illustrating the interdependent regulation of critical genes involved in the regulation of cell growth, proliferation and apoptosis.
HuR is a multifunctional protein, a member of the ELAV family of RNA-binding proteins that has been implicated in a variety of RNA metabolism processes including mRNA stability and translational control. 34 Interestingly, HuR appears to play a dual role in the regulation of cell death and survival. It has been shown to orchestrate both the pro-and anti-apoptotic cascades depending on the upstream pathways that are triggered. It is believed that activation of distinct signaling pathways triggers HuRdependent control of specific groups of mRNAs (HuR regulons), thereby altering the cellular state. 35 HuR prevents cell death by upregulating expression of inhibitors of apoptosis such as XIAP, ProT-α, p21, p53 and Survivin. 15, [36] [37] [38] Conversely, HuR suppresses pro-apoptotic factors such as Fas1. 39 This HuR-dependent prosurvival regulation correlates well with the observations that HuR levels are elevated in numerous cancers and suggests that HuR could attenuate cell death from occurring in malignant cells and tumors, thereby promoting resistance to radiation and chemotherapies. 40 However, other data suggests that when cellular stress is prolonged or lethal, a threshold is reached where HuR engages the apoptotic cascade. For example, upon staurosporine treatment, HuR is translocated to the cytoplasm in association with apoptosome activator pp32/PHAP-1 and is subsequently cleaved by caspases into a fragment (HuR-CP1) which was found to amplify the apoptotic response. 41 Interestingly, it was observed that in muscle cells the HuR-CP1 fragment caused cytoplasmic accumulation of full length HuR and subsequent enhancement of myogenesis. 42 Our data places Bcl xL within the HuR-regulated operon and shows that HuR, in addition to directly orchestrating cellular antiapoptotic program also contributes to the control of mitochondrial morphology.
Material and Methods
Cell culture, expression constructs and transfection. U2OS and HEK293 cells were maintained at 37°C, 5% CO 2 in complete Gibco ® 's DMEM (1% FBS, 1% glutamine, 100,000 U/L penicillin and 100 μg/L streptomycin). The bicistronic reporter plasmid pßgal/BclxL/CAT has been described previously 14 and contains the 5' UTR of Bcl xL . 12 The GST-HuR and GFP-HuR expressing plasmids were described previously. 41 For siRNA knockdown experiments, 1.5x10 5 cells were reverse transfected in a 6-well plate with 10 nM HuR siNRA, 30 nM Bcl xL siRNA, or corresponding non-silencing controls (Dharmacon) following the manufacturer's protocol (Lipofectamine™ RNAiMAX, Invitrogen). Cells were harvested 72 h later. For overexpression experiments, 1.5x10 5 cells were seeded in a 6-well plate for 24 h, then 2 μg of GFP or GFP-HuR plasmid DNA was transfected following the manufacturer's protocol (JetPrime™, Polyplus Hoechst dye was added (1 μg/mL) for 10 min to stain the nuclei and cells were washed 4x for 5 min in phosphate-buffered saline prior to mounting. Coverslips were mounted on slides using Dako Fluorescent Mouting Medium. Confocal microscopy was performed using the 60X objective with water (Olympus Fluoview FV1000, Richmond Hill, Ontario Canada).
Statistical analysis. All data are expressed as means ± standard error of the mean (SE), with a minimum of three independent experimental replicates unless otherwise noted. For reporter assays and for quantitative RT-PCR, independent replicates consisted of three biological triplicate experiments. A student t-test was performed to determine data significance using GraphPad Prism version 5.04 for Windows (GraphPad Software, San Diego, CA).
Disclosure of Potential Conflicts of Interest
No potential conflicts of interest were disclosed.
Acknowledgments
We thank the members of the Apoptosis Research Centre and Drs. Martin Pelchat and Jocelyn Côté for critical discussion, and Dr. Imed Gallouzi for the generous gift of HuR-expression constructs. This work forms part of the M. For splice-specific variant RT-PCR, the cDNA was used as a template in standard PCR with KOD polymerase and primers Bcl-X2 and Bcl-X3 as described. 44 Polysome profiling. HEK293 cells were reverse transfected with 10 nM HuR siRNA or non-silencing control siRNA for 72 h in 6-well plates (2 plates per condition) and polysome isolation was done as described.
14 Gradient fractions were collected from the top using the ISCO Teledyne programmable gradient fractionation system, and RNA was monitored at 254 nm. RNA was isolated from individual fractions (1 ml) by proteinase K digestion followed by phenol-chloroform extraction and ethanol precipitation. Equal quantities of RNA from each fraction were used to generate cDNA as described above. Quantitative RT-PCR was used to determine the abundance of Bcl xL and GAPDH mRNA in each fraction as described above.
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